Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo Models.
第一作者:
Lewis H,Bender
第一单位:
Intensity Therapeutics, Inc., Westport, CT 06880, USA.
作者:
医学主题词
动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);乳腺肿瘤(Breast Neoplasms);辛酸盐类(Caprylates);细胞增殖(Cell Proliferation);顺铂(Cisplatin);结肠肿瘤(Colonic Neoplasms);药物调剂(Drug Compounding);女(雌)性(Female);人类(Humans);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);肿瘤细胞, 培养的(Tumor Cells, Cultured);长春碱(Vinblastine);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.3390/ijms21124493
PMID
32599852
发布时间
2024-03-29
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



